Company intelligence / Profile preview

Arizona Allergy & Immunology Research

Scottsdale, Arizona, USA

Ownership: Private
Development stage: Other

Overview

Medical Research of Arizona conducts a wide range of industry-sponsored clinical trials in allergy, asthma, and immunology, contributing to FDA approvals for several therapies. They are active in both biological and small molecule drug development and device studies, with notable participation in trials for dupilumab, omalizumab, mepolizumab, reslizumab, and others.

Therapeutic areas: PulmonologyDermatologyImmunology
Modalities: Monoclonal antibodySmall moleculeProteinVaccineDevice
Industry: Contract Research Organization

Beyond the preview

Go deeper on Arizona Allergy & Immunology Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arizona Allergy & Immunology Research.

Explore the full profile